vs

Side-by-side financial comparison of Bowhead Specialty Holdings Inc. (BOW) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Bowhead Specialty Holdings Inc. is the larger business by last-quarter revenue ($151.7M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). Bowhead Specialty Holdings Inc. runs the higher net margin — 9.8% vs -38.1%, a 47.8% gap on every dollar of revenue.

Bowhead Specialty Holdings Inc. is a specialty insurance holding company that offers a diversified portfolio of property and casualty insurance products, focusing on underserved niche market segments primarily across North America. It provides tailored risk management solutions and specialized coverage options for both commercial and individual clients.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

BOW vs PRCT — Head-to-Head

Bigger by revenue
BOW
BOW
1.8× larger
BOW
$151.7M
$83.1M
PRCT
Higher net margin
BOW
BOW
47.8% more per $
BOW
9.8%
-38.1%
PRCT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BOW
BOW
PRCT
PRCT
Revenue
$151.7M
$83.1M
Net Profit
$14.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
11.7%
-4.1%
Net Margin
9.8%
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.44
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOW
BOW
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$151.7M
$76.4M
Q3 25
$143.9M
$83.3M
Q2 25
$133.3M
$79.2M
Q1 25
$122.7M
$69.2M
Q4 24
$68.2M
Q3 24
$116.8M
$58.4M
Q2 24
$98.9M
$53.4M
Net Profit
BOW
BOW
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$14.8M
$-29.8M
Q3 25
$15.2M
$-21.4M
Q2 25
$12.3M
$-19.6M
Q1 25
$11.4M
$-24.7M
Q4 24
$-18.9M
Q3 24
$12.1M
$-21.0M
Q2 24
$5.5M
$-25.6M
Gross Margin
BOW
BOW
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
BOW
BOW
PRCT
PRCT
Q1 26
-4.1%
Q4 25
11.7%
-40.6%
Q3 25
13.3%
-27.8%
Q2 25
11.9%
-28.0%
Q1 25
11.8%
-39.7%
Q4 24
-28.9%
Q3 24
13.5%
-38.4%
Q2 24
7.5%
-50.3%
Net Margin
BOW
BOW
PRCT
PRCT
Q1 26
-38.1%
Q4 25
9.8%
-39.1%
Q3 25
10.5%
-25.7%
Q2 25
9.3%
-24.7%
Q1 25
9.3%
-35.8%
Q4 24
-27.6%
Q3 24
10.4%
-35.9%
Q2 24
5.6%
-48.0%
EPS (diluted)
BOW
BOW
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.44
$-0.54
Q3 25
$0.45
$-0.38
Q2 25
$0.36
$-0.35
Q1 25
$0.34
$-0.45
Q4 24
$-0.34
Q3 24
$0.36
$-0.40
Q2 24
$0.20
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOW
BOW
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$193.5M
$245.6M
Total DebtLower is stronger
$146.4M
$51.7M
Stockholders' EquityBook value
$448.3M
$347.7M
Total Assets
$2.4B
$487.1M
Debt / EquityLower = less leverage
0.33×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOW
BOW
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$193.5M
$286.5M
Q3 25
$197.9M
$294.3M
Q2 25
$114.8M
$302.7M
Q1 25
$88.0M
$316.2M
Q4 24
$333.7M
Q3 24
$132.9M
$196.8M
Q2 24
$180.3M
$214.1M
Total Debt
BOW
BOW
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$146.4M
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
BOW
BOW
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$448.3M
$365.9M
Q3 25
$430.2M
$380.3M
Q2 25
$407.2M
$385.8M
Q1 25
$391.0M
$389.2M
Q4 24
$402.2M
Q3 24
$364.7M
$241.2M
Q2 24
$339.9M
$251.8M
Total Assets
BOW
BOW
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$2.4B
$508.1M
Q3 25
$2.1B
$511.5M
Q2 25
$1.9B
$513.1M
Q1 25
$1.8B
$519.4M
Q4 24
$534.0M
Q3 24
$1.5B
$374.1M
Q2 24
$1.4B
$374.4M
Debt / Equity
BOW
BOW
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.33×
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOW
BOW
PRCT
PRCT
Operating Cash FlowLast quarter
$331.6M
Free Cash FlowOCF − Capex
$326.0M
FCF MarginFCF / Revenue
214.9%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
22.34×
TTM Free Cash FlowTrailing 4 quarters
$593.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOW
BOW
PRCT
PRCT
Q1 26
Q4 25
$331.6M
$-10.3M
Q3 25
$114.7M
$-6.6M
Q2 25
$109.0M
$-15.0M
Q1 25
$47.7M
$-17.0M
Q4 24
$-32.4M
Q3 24
$119.4M
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
BOW
BOW
PRCT
PRCT
Q1 26
Q4 25
$326.0M
$-12.2M
Q3 25
$113.5M
$-9.5M
Q2 25
$107.4M
$-17.8M
Q1 25
$46.5M
$-18.8M
Q4 24
$-33.6M
Q3 24
$118.4M
$-19.0M
Q2 24
$-16.8M
FCF Margin
BOW
BOW
PRCT
PRCT
Q1 26
Q4 25
214.9%
-15.9%
Q3 25
78.8%
-11.4%
Q2 25
80.6%
-22.5%
Q1 25
37.9%
-27.2%
Q4 24
-49.2%
Q3 24
101.4%
-32.6%
Q2 24
-31.4%
Capex Intensity
BOW
BOW
PRCT
PRCT
Q1 26
Q4 25
3.7%
2.4%
Q3 25
0.9%
3.4%
Q2 25
1.2%
3.5%
Q1 25
1.0%
2.7%
Q4 24
1.7%
Q3 24
0.9%
0.4%
Q2 24
2.0%
Cash Conversion
BOW
BOW
PRCT
PRCT
Q1 26
Q4 25
22.34×
Q3 25
7.56×
Q2 25
8.83×
Q1 25
4.18×
Q4 24
Q3 24
9.88×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOW
BOW

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons